"ATP plays a critical role in the human body," said Larry Kolb, TSI Health Sciences president, U.S. operations. "This VendorWorks will serve as a forum to discuss the recent discoveries of specific families of ATP and adenosine receptors that have been shown to regulate virtually every physiological function, and why these discoveries are generating worldwide interest in oral ATP. Dr. Rapport will also explain why recent evidence suggests that the loss of physiological ATP pools is a leading factor in the aging process."

Eliezer Rapaport, Ph.D.
Dr. Rapaport was the first to make the revolutionary discovery that the administration of adenosine 5'-triphosphate (ATP) results in the immediate expansion of liver, blood and plasma (extra cellular) pools (steady state levels) of ATP. He further discovered and characterized the physiological and pharmacological roles of normal and expanded pools of organ, blood and blood plasma ATP pools in the treatment of clinical indications and aging. His work has helped to establish therapeutic and nutritional applications of ATP benefiting cardiac, liver and skeletal muscle functions and organ protection, vascular health, glycemic (blood sugar) control, regulation of weight loss, treatment of type II diabetes and arthritic diseases. Dr. Rapaport earned his Ph.D. in organic chemistry from Johns Hopkins University in 1971. Since that time, he has served on the faculties of Harvard Medical School at the Massachusetts General Hospital, Boston University School of Medicine, and Worcester Foundation for Experimental Biology. His research activities are described in 57 published, original, peer-reviewed articles.

PEAK ATP(R)
PEAK ATP is covered by a broad portfolio of patents, licensed from Dr. Eliezer Rapaport. Produced through a proprietary fermentation process, PEAK ATP delivers the exact molecule the human body needs to create energy. Extensive scientific evidence shows that PEAK ATP has a dramatic effect on circulation without adversely affecting heart rate or blood pressure. Never before has ATP been legitimately available for dietary supplement use. Other dietary supplements may claim to enhance physiological ATP synthesis, but only the exogenous administration of ATP itself has been scientifically proven to effectively elevate ATP levels. TSI works closely with its manufacturing licensees to ensure the proper technology is utilized in order to enhance the absorption of ATP into the bloodstream. PEAK ATP has applications for energy, athletic performance and anti-aging.

TSI Health Sciences
TSI Health Sciences, www.tsiinc.com, has evolved throughout the last decade to focus primarily on in-house, high-end ingredient production and has become a leading developer, producer and marketer of nutraceutical ingredients to the dietary supplement, pharmaceutical and food and beverage industries. With US operations based in Missoula, Mont., TSI was founded in 1996 and has offices worldwide, including a 60-acre, fully integrated manufacturing, research, quality assurance and quality control campus in Jiangyin, China. The company's comprehensive product range includes botanical, marine and natural product extracts, as well as synthesized compounds. TSI guarantees full-service cGMP manufacturing through TSI Manufacturing Systems, with divisions specializing in small and large-scale botanical and natural product extraction, large-scale chemical synthesis production and secondary processing capabilities. To learn more about TSI visit booth #7053-7055.

SupplySide West The SupplySide West trade show is dedicated to bringing together manufacturers and suppliers in the dietary supplement, food, pharmaceutical and cosmetic industries. The event provides a unique opportunity for an executive level exchange of ideas, goods and services not available through other any other business-to-business event. SupplySide West offers three days of informative seminars and exhibitions tailored to the specific needs of supply chain executives. For more information visit www.supplysideshow.com/west.